Release Date: 31/07/12 12:33 Summary: Appendix 4C - quarterly Price Sensitive: Yes Download Document 83.37KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%